Creative Medical Technology Holdings Inc (CELZ) USD0.001
- Add to watchlist
- This stock can be held in a
Business summary
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company. The Company is focused on the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. The Company conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction, respectively. The CaverStem and FemCelz kits are available through physicians at eight locations in the United States. Its products include StemSpine, ImmCelz, and OvaStem. StemSpine is a regenerative stem cell procedure for the treatment of degenerative disc disease. ImmCelz is a universal donor stem cell therapy for stroke treatment. OvaStem is a stem cell therapy for premature ovarian failure.
Contact details
Important dates
General stock information
- Short code:
- CELZ
- ISIN:
- US22529Y4089
- Market cap:
- $6.99 million
- Shares in issue:
- 1.36 million
- Sector:
- Biotechnology
- Exchange:
- NASDAQ
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.